Binding partners for the COOH-Terminal appendage domains of the GGAs and gamma-adaptin by Lui, Winnie W. Y. et al.
Molecular Biology of the Cell
Vol. 14, 2385–2398, June 2003
Binding Partners for the COOH-Terminal Appendage
Domains of the GGAs and -Adaptin
Winnie W.Y. Lui,* Brett M. Collins,*† Jennifer Hirst,*† Alison Motley,*
Caroline Millar,* Peter Schu,‡ David J. Owen,* and Margaret S. Robinson*§
*Department of Clinical Biochemistry, Cambridge Institute for Medical Research, University of
Cambridge, Cambridge CB2 2XY, United Kingdom; and ‡Department of Biochemie II, Zentrum fu¨r
Biochemie und Molekulare Zellbiologie, Universita¨t Go¨ttingen, D-37073 Go¨ttingen, Germany
Submitted November 15, 2002; Revised January 28, 2003; Accepted February 5, 2003
Monitoring Editor: Suzanne R. Pfeffer
The adaptor appendage domains are believed to act as binding platforms for coated vesicle
accessory proteins. Using glutathione S-transferase pulldowns from pig brain cytosol, we find
three proteins that can bind to the appendage domains of both the AP-1  subunit and the GGAs:
-synergin and two novel proteins, p56 and p200. p56 elicited better antibodies than p200 and was
generally more tractable. Although p56 and -synergin bind to both GGA and  appendages in
vitro, immunofluorescence labeling of nocodazole-treated cells shows that p56 colocalizes with
GGAs on TGN46-positive membranes, whereas -synergin colocalizes with AP-1 primarily on a
different membrane compartment. Furthermore, in AP-1–deficient cells, p56 remains membrane-
associated whereas -synergin becomes cytosolic. Thus, p56 and -synergin show very strong
preferences for GGAs and AP-1, respectively, in vivo. However, the GGA and  appendages share
the same fold as determined by x-ray crystallography, and mutagenesis reveals that the same
amino acids contribute to their binding sites. By overexpressing wild-type GGA and  appendage
domains in cells, we can drive p56 and -synergin, respectively, into the cytosol, suggesting a
possible mechanism for selectively disrupting the two pathways.
INTRODUCTION
Adaptor proteins (APs) are vesicle coat components that
were first identified as polypeptides enriched in purified
clathrin-coated vesicles. Two types of adaptor complexes
were originally described, AP-1 and AP-2, which localize to
the trans-Golgi network (TGN) and/or endosomal compart-
ments and to the plasma membrane, respectively. More
recently two other types of adaptor complexes have been
identified, AP-3 and AP-4. All four complexes are heterotet-
ramers, consisting of two large subunits, /// and 1/
2/3/4, a medium-sized or  subunit, and a small or 
subunit (Robinson and Bonifacino, 2001). The COOH-termi-
nal domains of the two large subunits project from the
complexes like appendages or ears and are thought to act as
binding platforms for accessory proteins. These domains
have been most extensively studied in the AP-2 complex,
where a number of proteins have been shown to bind either
directly or indirectly to the appendage domain of the 
subunit. Several of these proteins in turn make connections
with other molecules, including components of the actin
cytoskeleton, lipids, cargo proteins, and proteins involved in
signaling pathways (Slepnev and De Camilli, 2000). Some of
the binding partners for the  appendage are also able to
bind to the 2 appendage (Owen et al., 2000). The first
binding partner to be identified for the appendage domain
of the AP-1  subunit was the EH domain-containing protein
-synergin (Page et al., 1999). Glutathione S-transferase
(GST) pulldowns indicate that the  appendage can bind to
additional proteins in vitro, although it is less clear whether
these proteins are associated with AP-1 in vivo (Hirst et al.,
2000; Kent et al., 2002).
The structures of the , 2, and  appendages have all
been solved by x-ray crystallography (Owen et al., 1999;
Traub et al., 1999; Owen et al., 2000; Kent et al., 2002). To-
gether with the recently determined structure of the AP-2
core (Collins et al., 2002), these structures provide a detailed
model of how adaptor complexes are assembled at the mo-
lecular level. Despite little sequence homology, the  and 2
appendages share a similar overall structure consisting of
two subdomains: an NH2-terminal  sandwich subdomain,
which acts as a presentation scaffold for a COOH-terminal
“platform” subdomain. The COOH-terminal platform con-
tains a hydrophobic pocket that recognizes DF/W se-
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quences in the various appendage domain binding partners.
The  appendage has virtually no sequence homology to
either the  or  appendages, and it is approximately half
their size. However, it has an almost identical fold to the
NH2-terminal subdomain of both the  and  appendages.
This is particularly surprising because functionally the 
appendage is more similar to the  and  COOH-terminal
subdomain, which binds to the accessory proteins. Mutagen-
esis studies have revealed an entirely different mechanism
for accessory protein binding by the  appendage, involving
residues situated at the junction between the two sheets of
the  sandwich (Kent et al., 2002).
Recently, another family of adaptor proteins has been
identified, the GGAs. There are three GGA genes in mam-
mals, encoding proteins that colocalize with each other, and
two GGA genes in yeast, encoding proteins that seem to
be functionally interchangeable (Boman et al., 2000;
Dell’Angelica et al., 2000; Hirst et al., 2000). Studies in both
mammalian cells and yeast indicate that the GGAs facilitate
the trafficking of cargo receptors, including (in mammalian
cells) the mannose 6-phosphate receptors (MPRs) for lyso-
somal enzymes, from the TGN to an endosomal compart-
ment (Robinson and Bonifacino, 2001). AP-1 has also been
implicated in this pathway, raising the question of why the
cell needs both types of adaptors. Several recent studies
suggest that AP-1 may in fact be more important in retriev-
ing proteins such as the MPRs from an endosomal compart-
ment for recycling back to the TGN (Meyer et al., 2000, 2001;
Valdivia et al., 2002).
Unlike the AP complexes, the GGAs seem to be mono-
meric. However, they are able to incorporate all of the
functions of an adaptor complex into a single polypeptide,
making use of distinct domains involved in cargo selection,
membrane association, and clathrin binding (Puertollano et
al., 2001a,b). At the COOH-terminal end is a domain related
to the appendage domain of the  subunit of AP-1. The
homology between the GGA and  appendage domains
suggests that the two may recruit some of the same partners,
and indeed GST pulldowns by using pig brain cytosol as a
source of potential binding partners suggest that the GGA
appendages bind to a subset of those proteins that bind to
the  appendage (Hirst et al., 2000). Western blotting indi-
cates that one of these proteins is -synergin; however, the
relevance of this interaction in vivo is still not clear (Hirst et
al., 2000; Takatsu et al., 2000). In yeast, deleting the COOH-
terminal appendage domain impairs GGA function, al-
though such proteins are still partially functional (Hirst et al.,
2001; Mullins and Bonifacino, 2001). Chimeric constructs, in
which the GGA appendage has been replaced by the 
appendage, are fully functional, further supporting the view
that the two domains may recruit some of the same proteins
(Hirst et al., 2001).
In our previous study, we were able to identify only three
of the bands that came down with the  appendage and
none that came down with the GGA appendages. We have
now identified the remaining proteins. These include two
different isoforms of -synergin, presumably related to each
other by alternative splicing, and two novel proteins, p200
and p56. Here, we present an initial characterization of p56
and also address the question of how accurately the GST
pulldowns reflect interactions that occur in vivo. In addition,
we present the structure of the GGA appendage domain and
use mutagenesis to identify amino acids that are essential in
both the  and GGA appendages for binding to accessory
proteins.
MATERIALS AND METHODS
Constructs and Pulldowns
Most molecular biology techniques were carried out as described by
Sambrook et al. (1989). Reagents were purchased from Sigma-Al-
drich (St. Louis, MO) unless otherwise indicated. All of the poly-
merase chain reaction (PCR) products made for this study were
sequenced to ensure that no errors had been introduced. The GST-
coupled  appendage, GGA1 appendage, and GGA2 appendage
constructs and their use in GST pulldowns have been described
previously (Hirst et al., 2000). Gels of the pulldowns were stained
with Coomassie Blue and the bands excised and analyzed using
both matrix-assisted laser desorption ionization/time of flight
(MALDI TOF) and nanoelectrospray mass spectrometry by MDS
Protana (Odense, Denmark). p200 was able to be identified by
MALDI TOF alone, whereas -synergin and p56 were only able to
be identified by nanoelectrospray. Several point mutations (A563D,
V564D, V570E, and L572E) were introduced into the GGA1 append-
age by PCR, and these sequences were inserted into pGEX-4T for
pulldowns as described above. Green fluorescent protein (GFP)-
tagged appendage constructs were made using the vectors pEG-
FPC1 (for GGA1 and GGA2) and pEGFPC2 (for ) (BD Biosciences
Clontech, Palo Alto, CA).
p56 was originally identified as hypothetical protein FLJ11088.
Nine extended sequence tags (ESTs) with sequence overlapping that
of FLJ11088 were obtained from the IMAGE Consortium (MRC
Geneservice Hinxton, United Kingdom) and sequenced to assemble
a full-length contig: IMAGE clones 1307406, 1736582, 1866579,
2256993, 3062538, 3231483, 2604610, 1751619, and 743755. Because
none of these clones had inserts encoding the full-length protein, for
expression studies inserts from clones 1866579 and 1751619 were
ligated together by using a naturally occurring BamHI site. The
full-length sequence of p56 is available from GenBank/EMBL/
DDBJ database under accession no. AY289196. For expression in
mammalian cells, a myc tag was inserted into the NH2-terminal end
by PCR and the construct was cloned into pcDNA3. For expression
in Escherichia coli, a 6xHis tag was inserted, using either pQE30 (for
the experiment shown in Figure 2d) or pTrcHisA (for raising anti-
bodies against p56). For mapping the domains of p56, PCR was used
to amplify the appropriate regions and the products were ligated
into pTrcHisA. His-tagged constructs were purified using Ni-ni-
trilotriacetic acid agarose beads (QIAGEN, Valencia, CA). Cross-
linking was performed by incubating 10 g of fusion protein in 50
l of phosphate-buffered saline containing 2 mM dithiobis(succin-
imidyl propionate) (DSP) for 1.5 h. The sample was then boiled in
nonreducing sample buffer and subjected to SDS-PAGE followed by
Western blotting.
Antibodies
Antibodies were raised in rabbits against the two novel proteins
identified in this study, p200 and p56. For the p200 antibodies, clone
KIAA1414 (generously provided by the Kazusa DNA Research
Institute, Chiba, Japan) was used as a template to amplify the
coding sequence for amino acids 946-1217 by PCR, and the product
was ligated into pGEX4T-1 (Amersham Biosciences, Piscataway,
NJ). The resulting GST fusion protein was soluble and was purified
as specified by the manufacturer. Rabbits were immunized with the
GST-p200 construct and with the His-p56 construct described
above, and the antisera were affinity purified as described previ-
ously (Page et al., 1999).
Western blotting was performed using the above-mentioned an-
tibodies, as well as antibodies against -synergin (Page et al., 1999)
and the Xpress epitope (Invitrogen, Carlsbad, CA), followed by
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125I-protein A. Ligand blotting was performed using either GST
alone or one of the GST constructs, followed by anti-GST and
125I-protein A (Amersham Biosciences) (Page et al., 1999). For pep-
tide competition experiments, a 15-residue peptide was synthesized
by Sigma Genosys (The Woodlands, TX) and added to the incuba-
tion mixture in the appropriate buffer at the indicated concentra-
tions. Immunofluorescence was performed on either methanol-ace-
tone fixed cells or paraformaldehyde-fixed cells as described
previously, by using anti-p56 (this study), anti-GGA1 (Hirst et al.,
2000), anti--synergin (Page et al., 1999), anti-FLAG (Sigma-Al-
drich), anti-myc monoclonal antibody 9E10 (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA), rabbit polyclonal anti--adaptin (Seaman et
al., 1996), and mouse monoclonal anti--adaptin monoclonal anti-
body 100/3 (Sigma-Aldrich). Secondary antibodies were purchased
from Molecular Probes (Eugene, OR). Cells were viewed using an
Axiophot fluorescence microscope (Carl Zeiss, Jena, Germany)
equipped with a charge-coupled device camera (Princeton Scientific
Instruments, Monmouth Junction, NJ). Photographs were recorded
using IP Labs software and then moved into Adobe Photoshop.
Cells
COS cells were used for most immunofluorescence experiments. For
some experiments, they were transiently transfected with myc-
tagged p56 by using FuGENE 6 (Roche Diagnostics, Mannheim,
Germany) and fixed the following day. COS cells were also tran-
siently transfected with the GFP-appendage constructs described
above. For some experiments, normal rat kidney cells stably trans-
fected with FLAG-tagged GGA2 were used (Hirst et al., 2000). To
investigate the distribution of proteins in AP-1–deficient cells, fi-
broblasts from a 1A knockout mouse were used, and the same cell
line stably transfected with wild-type 1A was used as a control
(Meyer et al., 2000). To examine the distribution of various proteins
in microtubule-disrupted cells, the cells were treated with 20 g/ml
nocodazole for 2 h at 37°C before fixation. To investigate the distri-
bution of p56 after brefeldin A (BFA) treatment, cells were incu-
bated with 5 g/ml BFA for 2 min and then fixed immediately.
Crystallization of the GGA1 Appendage
A cDNA fragment encoding residues 494–639 of human GGA1 was
cloned by standard PCR procedures and expressed in E. coli with an
NH2-terminal 6xHis tag. The protein was purified by Ni-nitrilotri-
acetic acid affinity chromatography, followed by gel filtration in 5
mM HEPES (pH 7.5), 100 mM NaCl. The protein was concentrated
to 37 mg/ml and crystallized by sitting drop vapor diffusion in 100
mM sodium citrate (pH 5.6), 1.7 M ammonium sulfate. Crystals
grew to maximum dimensions of 1 0.8 0.25 mm within 24 h and
belong to space group P3221 with unit cell dimensions a  65.4 Å,
b  65.4 Å, c  142.7 Å,     90°, and   120°. In our crystals,
we observe an extensive interface between two separate GGA1
proteins in the asymmetric unit; however, we do not see any evi-
dence for dimerization in solution by using either gel filtration or
dynamic light scattering, suggesting that this is not an in vivo
natural dimeric interaction.
Data Collection and Structure Determination
Crystals were mounted in mother liquor containing 20% (vol/vol)
glycerol, and data collected at 100 K by using a Rigaku rotating
anode x-ray source fitted with a MAR345 image plate detector. A
data set was collected to 2.3-Å resolution, integrated with MOSFLM
(Leslie, 1992), and scaled using CCP4 programs (Dodson et al., 1997).
The statistics are given in Table 1. Initial phases were determined by
molecular replacement by using the  ear as a trial model (PDB ID
1GYU; Kent et al., 2002). The position of the first molecule in the
asymmetric unit was determined using Amore (r  26.1; R-factor 
54.0). The position of the first molecule was then fixed and initial
rotation function solutions used to search for the refined rotation
and translation parameters of the second chain. The final solution,
with two molecules in the asymmetric unit, had an r value of 38.3
and an R-factor of 49.4 and produced a readily interpretable electron
density map after rigid body refinement in REFMAC5 (Murshudov
et al., 1997), clearly showing regions where the map differed from
the input model. The model was rebuilt in O (Jones et al., 1991) and
refined using REFMAC5. Simulated annealing omit maps were
routinely calculated in central nervous system (Brunger et al., 1998)
to minimize the introduction of model bias. The model was refined
to an Rcryst of 0.230 and Rfree of 0.305, after which translational
liberational shear refinement was implemented in REFMAC5 (Winn
et al., 2001), treating the two chains as separate rigid groups. This
resulted in a reduction of Rcryst and Rfree to 0.219 and 0.279, respec-
tively. The final model consists of two GGA1 appendage chains,
A489-A639 (including five residues of the N-terminal 6xHis tag),
B495-B639, and 175 water molecules. One residue (S499 of chain A)
falls in the disallowed region of the Ramachandran plot. This resi-
due has good electron density (average atomic B-factor  17.3 Å2),
and the distorted main-chain seems to be caused by a close crystal
contact.
RESULTS
Identification of Novel Appendage Binding Partners
We have previously shown that constructs consisting of GST
fused to the appendage domains of either  or GGAs bring
down a number of proteins from pig brain cytosol, three of
which (bands 2, 3, and 7) seem to interact with both  and
GGA appendages (Hirst et al., 2000; Figure 1a). Using
MALDI-TOF mass spectometry, we were able in our previ-
ous study to identify three of the bands in the pulldowns as
Table 1. Statistics of data collection and structure refinementa
Data collection
Resolution (Å) 57.0-2.3 (2.36-2.30)
Rmergeb 0.053 (0.306)
Rmeasc 0.058 (0.306)
I/_(I) 23.7 (5.9)
Completeness (%) 99.0 (99.0)
Multiplicity 5.6 (5.7)
Wilson plot B (Å2) 45
Refinement
Resolution 15-2.3 (2.36-2.30)
Rcryst (Rfree)d 0.219 (0.279)
B (Å2) 23.1
No. reflections (No. in Rfree) 15310 (813)
No. atoms (No. water atoms) 2499 (175)
Rmsd bond lengths (Å) 0.019
Rmsd bond angles (°) 1.72
Ramachandran plot (%)e
Most favoured region 89.0
Additionally allowed 10.6
Disallowed (residue name) 0.4 (Ser-A499)
a Unless otherwise stated, values in parentheses apply to the high-
resolution shell.
b Rmerge  _iPIhIhiP/_iIh where Ih is the mean intensity of reflec-
tion h.
c Rmeas  _  (n/n1)_iPIhIhiP/_iIh, the multiplicity weighted
Rmerge (Diederichs and Karplus, 1997).
d R  _(FPFcalc)/_FP.
e From PROCHECK (Laskowski et al., 1993).
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MAP1A (band 1), rabaptin-5 (band 4), and Hsc70 (band 6).
We have now analyzed the remaining bands by nanoelec-
trospray as well as MALDI-TOF mass spectometry. Band 2,
or p200, was matched with KIAA1414, a protein of unknown
function. Band 3 was found to be -synergin. Although
-synergin sequences from both rat and human are available
in the database, the pig protein is presumably too divergent
to be identified by MALDI-TOF (the human and rat se-
quences are only 85% identical). Band 5, a doublet that is
present only in the  appendage pulldown, also matched
-synergin. Band 7, or p56, matched another novel protein,
FLJ11088.
To confirm these identities, antibodies were raised against
recombinant p200 and p56 and used together with our pre-
viously characterized antibody against -synergin to probe
Western blots of the pulldowns. Figure 1, b–d, shows that all
three antibodies give the expected pattern. Anti-p200 and
anti-p56 both label bands of the appropriate size in the  and
GGA pulldowns, but do not label bands in the pulldown
with GST alone, or in pulldowns with  appendage (our
unpublished data). The anti--synergin antibody labels
bands of 160 and 105 kDa in the  pulldown lane, but
only the higher molecular mass band in the GGA pulldown
lanes. These two forms of -synergin are most likely alter-
natively spliced variants of the protein, because we have
previously demonstrated that -synergin mRNA is alterna-
tively spliced in several different places, particularly in brain
(Page et al., 1999). Thus, we now have identities for all three
of the major bands brought down by the GGA appendages.
p56 Domains
Of the two novel proteins identified in this study, p56
proved to be much more tractable than p200. The full-length
sequence of p56 was determined by finding ESTs that over-
lap with FLJ11088 and with each other and sequencing
several of the clones. ESTs encoding p56 can be found from
a variety of tissues and organs, indicating that the gene is
expressed ubiquitously. There are at least four alternatively
spliced isoforms with different NH2 termini, as shown dia-
grammatically in Figure 2a. The isoform that occurs most
frequently in the database, which we call the common iso-
form, consists of exons 1, 3, 4, and 7–16, and its sequence is
shown in Figure 2b. Downstream from the alternatively
spliced NH2-terminal domain, there is a long stretch of
predicted coiled coil structure (Figure 2c).
To find out whether p56 binds directly to the appendage
domains, we probed Western blots of bacterially expressed
His-tagged p56 with GST coupled to , GGA1, or GGA2
appendage domains. Figure 2d shows that recombinant p56
is labeled with all three constructs but not with GST alone,
confirming that the interaction is direct. To determine which
part of p56 binds to the appendages, different regions of the
common isoform were expressed in bacteria as His/Xpress-
tagged constructs, indicated diagrammatically in Figure 2c.
Figure 2e shows that domain 1 (amino acids 1–119), up-
stream from the coiled coil domains, can be labeled by the
GGA1 appendage domain. None of the other domains were
labeled, indicating that the NH2-terminal domain is both
necessary and sufficient for this interaction.
To map the binding site more precisely, we first compared
the common isoform with a second isoform, consisting of
exons 5, 6, and 7–16, which seems to be expressed mainly in
testis. Only the common isoform was found to bind to a
GGA1 appendage domain construct (our unpublished data),
indicating that amino acids 1–36, encoded by exons 3 and 4,
contain the binding site. A comparison of the mouse and
human sequences revealed that amino acids 1–17 are iden-
tical, whereas amino acids 18–36 are poorly conserved. Be-
cause it seemed likely that the binding site would be con-
served, a 15-residue peptide, consisting of amino acids 2–16,
was tested for its ability to compete for appendage domain
binding to p56. Figure 2f shows that the peptide inhibits
binding by 50% at concentrations of between 10 and 100 M
in both overlays and pulldown assays. The inhibition is
somewhat more robust than that reported for DPF/W-con-
taining peptides, which need to be added at concentrations
of 500 M to compete effectively for binding between the
 appendage and its partners (Owen et al., 1999).
We also investigated the properties of the predicted coiled
coil portion of the protein. Figure 2, d and e, shows that both
the full-length His-tagged construct and domain 3 occur on
blots as a major band of the expected size, a small amount of
breakdown product, and a higher molecular mass band that
is exactly twice the apparent molecular mass of the major
band (see asterisks). Because coiled coil domains are often
involved in dimerization, this suggests that the protein may
be assembling into SDS-resistant homodimers. Further evi-
dence suggesting that p56 can form homodimers is shown in
Figure 2g. The His-tagged domain 3 construct was treated
Figure 1. Identification of proteins that bind to the  and GGA
appendages in vitro. Pig brain cytosol was incubated with GST
alone or with GST fusion proteins containing the appendage do-
mains of -adaptin (GST-), GGA1 (GST-GGA1), or GGA2 (GST-
GGA2). The Coomassie Blue-stained gel and the proteins identified
by mass spectometry are shown in a. Western blots of the appro-
priate region of the gel labeled with the indicated antibodies are
shown in b–d. p200 and p56 both come down with all three con-
structs, as does the larger isoform of -synergin. However, the
smaller isoform of -synergin (which runs as a doublet) only comes
down with the  appendage construct.
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Figure 2. Biochemical character-
ization of p56. (a) Genomic structure
of p56. The mRNA is alternatively
spliced in at least four different ways.
The most common isoform of p56,
which was used for all of the expres-
sion studies in tissue culture cells,
consists of exons 1, 3, 4, and 7–16
(dashed line, top). There is an in-
frame stop codon upstream from the
initiator methionine in exon 3. A
shorter isoform, which seems to be
expressed mainly in testis (based on
analysis of the EST database), con-
sists of exons 5, 6, and 7–16 (gray
line, top). In-frame stop codons are
found in exon 5. There is also an
entry in the database from ovary
(BM545687) encoding a larger pro-
tein, which consists of exons 1, 2, 3, 4,
6, and 7 onwards (solid line, bottom).
This protein has the same putative
start as the common isoform, but in-
cludes an extra 5UTR exon and an
extra exon in the coding region. This
exon (exon 6) includes the NH2-ter-
minal sequence of the shorter iso-
form. In addition, there are entries in
the database from both placenta
(AL544393) and cervix (BI086262),
consisting of exon 1 and exon 7 on-
wards (dotted line, bottom). The
open reading frame is maintained in
exon 1, with no start codon, suggest-
ing that the initiator methionine may
be in another exon further upstream.
Introns range in size from 94bp to
67kb. (b) Amino acid sequence of the
common isoform of human p56.
While our manuscript was under re-
view, full-length sequences of mouse
p56 were deposited in the database
under accession numbers BAB25348
(common isoform) and AAH28682
(testis isoform). (c) p56 is predicted to
form coiled coils. The p56 sequence
was analyzed using the COILS pro-
gram. The x-axis shows the amino
acid number; the y-axis shows the
probability of coiled coil formation.
The four domains used for the map-
ping experiment in e are indicated.
(d) p56 binds directly to the  and
GGA appendages. Full-length p56 was expressed in E. coli as a His-tagged protein and blots were overlaid with either GST alone, GST- appendage,
GST-GGA1 appendage, or GST-GGA2 appendage. The major band runs at the expected position, the lower band is presumably a breakdown product,
and the higher band (asterisk) may be an SDS-resistant homodimer. (e) Mapping of the appendage binding domain. The four domains indicated in b were
expressed as His/Xpress-tagged proteins, purified, and subjected to SDS-PAGE and Western blotting. Domain 1 contains amino acids 1–119, domain 2
contains amino acids 126–214, domain 3 contains amino acids 210–413, and domain 3	 4 contains amino acids 210–441. Blots were probed either with
anti-Xpress, to show the positions of the proteins, or with the GST-GGA1 appendage construct. The domain 3	 4 construct was expressed at lower levels
than the other constructs. Domain 1 binds to the GGA appendage. Note the higher molecular mass band in the lane containing domain 3 (asterisk), which
may be an SDS-resistant homodimer. (f) Peptide competition for binding. A 15-residue peptide derived from the NH2-terminal domain of the common
isoform of p56, DDDDFGGFEAAETFD, was added to the incubation mixtures. Top, a blot of domain 1 was probed with the GST-GGA1 appendage
construct with increasing concentrations of peptide. Bottom, the GST-GGA1 appendage construct was used to pull down proteins from pig brain cytosol
with increasing concentrations of peptide, and a Western blot of the pulldowns was probed with anti-p56. In both cases, competition is essentially complete
at 0.5 mM peptide. (g) Cross-linking of domain 3. Domain 3 was run on a nonreducing gel, either with or without first treating with the cross-linker DSP,
and the Western blot was probed with anti-Xpress. The anomalous mobility of the noncross-linked band is presumably due to the gel system. The band
in the cross-linked lane is approximately twice the apparent molecular mass of the band in the noncross-linked lane, suggesting that it has been
cross-linked into a homodimer. (h) Model of p56. The protein is predicted to form a coiled coil homodimer by using domains 2 and 3. The NH2-terminal
domain (domain 1) interacts with the GGA appendage domains. The COOH-terminal domain (domain 4), which is the most conserved part of the protein,
may interact with another binding partner(s).
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with the cross-linker DSP before running on a nonreducing
gel, next to a lane containing noncross-linked domain 3. The
band seen in the noncross-linked lane disappears in the
cross-linked lane and is replaced by a more diffuse band
with approximately twice the apparent molecular mass.
These results suggest that the central portion of p56 may
form a coiled coil homodimer, leaving the NH2-terminal
domain free to interact with GGA and/or  appendages,
whereas the small COOH-terminal domain may interact
with another binding partner. A schematic diagram of p56 is
shown in Figure 2h.
Localization of p56
To determine whether p56 is associated with AP-1 and/or
GGAs under physiological conditions, immunofluorescence
double labeling was carried out. Figure 3a shows that the
antibody we raised against p56 gives strong labeling of a
band of the appropriate size when used to probe blots of
total homogenates from pig brain and COS cells. When used
for immunofluorescence on COS cells, this antibody pro-
duces a perinuclear pattern (Figure 3b). We also inserted an
NH2-terminal myc tag into p56 and observed the same type
of pattern in transiently expressing cells labeled with an
anti-myc antibody (Figure 3c). Double labeling shows com-
plete coincidence between tagged p56 (c) and tagged plus
endogenous p56 (b) in the transfected cells. Treating cells
with the drug BFA for 2 min caused p56 to redistribute into
a grainy cytoplasmic pattern (Figure 3d). Thus, p56 behaves
in a similar manner to both AP-1 and the GGAs in BFA-
treated cells (Hirst et al., 2000).
To double label cells for GGAs and p56, we had to trans-
fect the cells with a tagged version of one of the two pro-
teins, because only rabbit antibodies are available against
either of them. Figure 3, e and f, shows double labeling for
FLAG-tagged GGA2 (e) and endogenous p56 (f). The pe-
rinuclear patterns are very similar, although there is some
background labeling seen with the anti-FLAG antibody.
Myc-tagged p56 produced less background (Figure 3h), and
again very similar patterns were seen compared with en-
dogenous GGA1 (Figure 3g). Figure 3, i–l, shows cells dou-
ble labeled for -adaptin (i and k) and either endogenous (j)
or myc-tagged (l) p56. The patterns overlap, but they are less
completely coincident than in cells double labeled for GGAs
and p56, suggesting that p56 may preferentially interact
with GGAs in vivo. However, it can be very difficult to
resolve different patterns when comparing two proteins that
both have a perinuclear distribution, because so many mem-
branes are concentrated in this part of the cell. Thus, we
needed to use other methods to compare the distributions of
these proteins.
Figure 3. Localization of p56.
(a) Western blot showing that the
anti-p56 antibody specifically la-
bels a band of the expected size in
both pig brain and COS cell ho-
mogenates. The lower molecular
mass band may be a degradation
product or a splice variant. (b and
c) Double labeling of COS cells
for endogenous plus tagged (b)
and myc-tagged (c) p56. The two
labeling patterns show complete
colocalization in the transfected
cells. (d) p56 is sensitive to BFA.
COS cells were treated with BFA
for 2 min and then labeled with
the antibody against the endoge-
nous protein. (e and f) Tagged
GGA2 (e) and endogenous p56 (f)
show good colocalization, al-
though there is some background
with the tagged GGA2. (g and h)
Endogenous GGA1 (g) and tagged
p56 (h) show excellent colocaliza-
tion. (i–l) -Adaptin (i) and endog-
enous p56 (j), or -adaptin (k) and
tagged p56 (l) have similar labeling
patterns but do not colocalize as
well as GGAs and p56. Bar, 25 m
(b–d); 20 m (e–l).
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Preferential Binding of p56 and -Synergin to
Different Partners
The first method that we used to compare the various label-
ing patterns was to treat the cells with the microtubule-
disrupting drug nocodazole (Figure 4). This causes mem-
branes whose distribution is dependent upon an intact
network of microtubules to scatter throughout the cell. Un-
der these conditions, AP-1 (a; red in c) and the GGAs (b;
green in c) generally have nonoverlapping distributions,
indicating that for the most part they are recruited onto
distinct membrane compartments. To try to identify these
compartments, we double labeled the cells with antibodies
against TGN46 (e and h; green in f and i) and either -adap-
tin (d; red in f) or GGAs (g; red in i). The GGAs show much
better colocalization with TGN46 than AP-1, consistent with
the hypothesis that GGAs act at the TGN, whereas AP-1 may
act mainly at a post-TGN compartment. Double labeling for
-adaptin (j; red in l) and tagged p56 (k; green in l) showed
little overlap between the two proteins. However, excellent
overlap was seen between GGAs (m; red in o) and tagged
p56 (n; green in o). Conversely, when we double labeled for
-adaptin (p; red in r) and -synergin (q; green in r) in
nocodazole-treated cells, we saw essentially complete colo-
calization.
Because it is formally possible that nocodazole may have
indirect effects on protein binding, we also used a second
approach to investigate the relative importance of AP-1 and
GGAs in the localization of p56 and -synergin. This was to
compare the distribution of all four proteins in cells with no
membrane-associated AP-1 complexes. The cells were de-
rived from a 1A (ubiquitously expressed AP-1 medium
chain) knockout mouse (Meyer et al., 2000). Although the
knockout is embryonic lethal, a fibroblast line was generated
from the embryos. The fibroblasts were shown to form par-
tial AP-1 complexes containing -adaptin, but such com-
plexes are unable to be recruited onto membranes (Figure
5a). Transfecting the cells with wild-type 1A restores the
ability of the cells to form functional, correctly localized
AP-1 (Figure 5b).
We looked first at the localization of the GGAs in the 1A
knockout and rescued cells. Figure 5, c and d, shows that
GGAs have a similar distribution whether or not the cells are
able to recruit AP-1 onto membranes. p56 also looks the
same in the knockout and rescued cells (Figure 5, e and f).
However, -synergin becomes completely cytosolic in the
knockout cells (Figure 5g), although it has a normal distri-
bution in the rescued cells (Figure 5h). Thus, membrane-
associated GGAs are unable to recruit -synergin onto mem-
branes in cells where AP-1 is cytosolic; however, the
distribution of p56 is not affected in such cells.
Together, these studies indicate that although p56 and
-synergin are able to interact with both GGA and  append-
ages in vitro, under physiological conditions p56 shows a
strong preference for the GGAs, whereas -synergin shows
a strong preference for -adaptin.
Structure of the GGA Appendage Domain
Sequence alignments of the GGA and  appendages show
that the two domains are significantly homologous to each
other (Hirst et al., 2000; Figure 6c). To compare the structures
of the two appendage domains, we have expressed the
GGA1 appendage (residues 494–639) in E. coli and deter-
mined its structure by x-ray crystallography. Crystals of the
GGA1 appendage diffract to better than 2.3-Å resolution,
and the structure was solved by molecular replacement
using the  appendage structure as a starting model (Kent et
al., 2002; PDB ID 1GYU). Like the  appendage, the GGA1
appendage is an eight-stranded  sandwich (Figure 6a).
Overlaying the structures of the GGA1 appendage (green),
the  appendage (orange), and the  appendage (magenta)
shows that the GGA1 appendage is structurally almost iden-
tical to the  appendage, and also shows a high degree of
similarity to the NH2-terminal subdomain of the  append-
age (Figure 6b).
The finding that the GGA and  appendages can bind to
a common subset of proteins suggests that the two do-
mains use a similar mechanism to interact with accessory
proteins. Structure-based mutagenesis of the  appendage
has allowed the identification of residues involved in the
binding of -synergin and Eps15 (Kent et al., 2002). To test
whether the GGA1 appendage can interact with its own
ligand, p56, in the same way, we have constructed a set of
mutants based on the -adaptin results. The residues that
have been shown to mediate protein interactions by the 
appendage are situated within a hydrophobic cleft that
lies at the interface between the two  sheets, with A753
and L762 the most important residues (Figure 6, a and c).
We have mutated the corresponding residues of GGA1 to
negatively charged amino acids (A563D and L572E) and
have also mutated two of the neighboring hydrophobic
residues (V564D and V570E). Circular dichroism analysis
indicates that the mutants all have an identical fold to the
native protein (our unpublished data). Figure 7a shows
that all four of these mutations abolish binding of the
GGA1 appendage to p56 in GST pulldowns, indicating
that GGAs bind to protein ligands in an identical manner
to the AP-1  subunit. The results also show that the
interaction is governed in part by hydrophobic interac-
tions, similar to the binding of the  and  appendage
domains to short peptides with the sequence DF (Owen
et al., 1999).
Distribution of p56 and -Synergin in Cells
Overexpressing Appendage Domains
It has been previously shown that overexpressing the ap-
pendage domain of the  subunit of the AP-2 complex has a
dominant negative effect and blocks clathrin-mediated en-
docytosis, presumably by sequestering binding partners that
are required for this event (Owen et al., 1999). To determine
whether overexpressing the GGA or  appendages might
have a similar effect, we transfected cells with GFP coupled
to either the wild-type GGA1 appendage domain, the
A563D mutant GGA1 appendage domain, or the wild-type 
appendage domain. The cells were then double labeled for
either p56 or -synergin.
Figure 7, b and c, shows that in cells expressing the
GFP-GGA wild-type construct (b), p56 is predominantly
cytosolic (c), presumably because the construct is expressed
at higher levels than endogenous GGAs and sequesters most
of the p56. In contrast, in cells expressing the A563D mutant
GGA construct (d), p56 looks normal (e). Moderate expres-
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Figure 4. Localization of proteins in nocodazole-
treated cells. COS cells were treated with 20 g/ml
nocodazole for 2 h to disperse membranes associ-
ated with the microtubule-organizing center. (a–c)
Cells were double labeled with anti--adaptin (a;
red in c) and anti-GGA1 (b; green in c). The two
adaptors have distinct punctate patterns, with
only 28% of the spots in this cell colocalizing. (d–f)
Cells were double labeled with anti--adaptin (d;
red in f) and anti-TGN46 (e; green in f). The two
proteins have distinct patterns (18% colocaliza-
tion), indicating that most of the AP-1 is not asso-
ciated with TGN membranes as defined by the
presence of TGN46. (g–i) Cells were double la-
beled with anti-GGA3 (g; red in i) and anti-TGN46
(h; green in i). The two proteins show good colo-
calization (71% of the spots are labeled with both
antibodies), indicating that GGA3 is associated
with TGN membranes. Similar results were seen
with anti-GGA1 and with anti-p56 (our unpub-
lished observations). (j–l) Transiently transfected
cells expressing myc-tagged p56 were double la-
beled with anti--adaptin (j; red in l) and anti-myc
(k; green in l). The two patterns are distinct (12%
colocalization). (m–o) Transiently transfected cells
expressing myc-tagged p56 were double labeled
with anti-GGA1 (m; red in o) and anti-myc (n;
green in o). The two patterns show essentially
complete colocalization on membranes (98%).
(p–r) Cells were double labeled with anti--adap-
tin (p; red in r) and anti--synergin (q; green in r).
The two patterns show excellent colocalization
(99%). Bar, 20 m.
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sion of the wild-type GGA construct (f) has little effect on the
distribution of -synergin (g). However, moderate expres-
sion of the  appendage construct (h) causes -synergin (i) to
redistribute to the cytosol. Conversely, moderate expression
of the  construct has little effect on p56 (j and k). Thus, these
experiments provide further evidence that the distribution
of p56 and -synergin is primarily determined by the distri-
bution of the appendage domains of GGAs and AP-1, re-
spectively. In addition, they suggest a possible means
whereby one might be able to selectively block either the
GGA pathway or the AP-1 pathway and then look at effects
on the trafficking of other proteins.
Figure 5. Localization of proteins in 1A-defi-
cient cells. Fibroblasts lacking 1A (1A deficient)
as well as the same cell line stably transfected with
wild-type 1A (1A rescued) were labeled with
antibodies against either -adaptin (a and b),
GGA1 (c and d), p56 (e and f), or -synergin (g
and h). Both -adaptin and -synergin are cytoso-
lic rather than membrane associated in the 1A-
deficient cells. However, the distribution of GGA1
and p56 is not affected, indicating that -synergin
requires AP-1 to get onto the membrane, but
GGA1 and p56 do not. Bar, 20 m.
GGA and -Adaptin Binding Partners
Vol. 14, June 2003 2393
DISCUSSION
The discovery of the GGAs was reported in 2000 by several
groups who had independently used different approaches to
find these proteins (Boman et al., 2000; Dell’Angelica et al.,
2000; Hirst et al., 2000; Poussu et al., 2000; Takatsu et al.,
2000). Our own approach had been to search databases for
proteins with homology to known adaptor subunits (Hirst et
al., 2000). We identified the GGAs as proteins with COOH-
terminal domains that were related to the appendage do-
main of the AP-1  subunit. At the time, we proposed that
the GGA and  appendage domains might bind some of the
same partners. The sequence homology also suggested that
the two domains might share a similar structure. Here, we
show that both hypotheses are correct. We have identified
the three bands visible by Coomassie Blue staining that
come down with both GGA and  appendages in GST
pulldowns and have shown that they are indeed the same
proteins: p200, -synergin, and p56. We have also shown
that both appendage domains have a  sandwich fold and
that they interact with protein ligands in an identical man-
ner. Binding by both GGA and  appendages to accessory
proteins is governed by conserved residues lying within a
shallow cleft where the two  sheets come together. These
interactions are probably mediated in part by a hydrophobic
contact, because mutation of hydrophobic residues com-
pletely abolishes binding. Thus, this study clearly indicates
why the two appendage domains are able to bind to an
overlapping set of proteins.
Of the three proteins that bind to both GGA and  ap-
pendages in the pulldowns from pig brain cytosol, the one
we know least about is p200. It contains no obvious domains
or motifs, and we were unable to raise antibodies against it
that were specific enough for immunolocalization studies.
Epitope tagging has also proved problematic because of the
large size of the protein and our inability so far to clone the
5 end. It is the most well conserved of the three proteins,
with homologs in flies, worms, and yeast, suggesting that it
may have a more fundamental role than either -synergin or
p56. However, when we delete the p200 homolog in yeast,
we see no apparent phenotype. The cells are completely
viable, and the sorting and processing of carboxypeptidase
Y and -factor, both of which are aberrant in GGA-deficient
cells (Hirst et al., 2000 and 2001), remain normal in p200-
deficient cells (Hirst, unpublished observations). This sug-
gests that p200 may be functionally redundant in yeast.
Although Saccharomyces cerevisiae contains no other obvious
homologues of p200, there may be another protein or pro-
teins that can perform the same role.
-Synergin is the only one of the three shared binding
partners that had already been identified and characterized.
Figure 6. Structure of the GGA1
appendage domain and compari-
son with the  and  appendages.
(a) Structure of the GGA1 ap-
pendage shown as a ribbon dia-
gram. The residues that have
been mutated in GGA1 for pro-
tein–protein interaction studies
are indicated as ball and stick
representations. (b) C overlay of
the GGA1 appendage (green)
with the  appendage (orange)
(Kent et al., 2002) and the  ap-
pendage (magenta) (Owen et al.,
1999). The  appendage overlays
the GGA1 appendage with an
rmsd of 1.2 Å 
 113 C atoms.
Figures were made with AESOP
(Collins et al., 2002). (c) Structure-
based sequence alignment of
GGA1 and  appendage do-
mains. The secondary structure
of the GGA1 appendage is shown
as green arrows, and conserved
residues are highlighted in gray.
The region shown to bind p56 by
mutagenesis is boxed in red.
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In our previous study, we showed by Western blotting that
-synergin could be pulled down by both  and GGA ap-
pendages (Hirst et al., 2000). We have now confirmed this
result by mass spectrometry and have shown that -syner-
gin corresponds to two of the Coomassie Blue-stained bands
in the pulldowns. In our previous study, we also proposed
that the interaction between -synergin and the GGA ap-
pendages might not take place in vivo. This was based on
our finding that -synergin could be coimmunoprecipitated
with -adaptin but not with GGA1 or GGA2 and that it
completely colocalized with -adaptin but not with the
GGAs by immunofluorescence. More recently, Nakayama
and coworkers have shown that -synergin interacts with
GGAs in the yeast two-hybrid system, and they also saw
what seemed to be significant colocalization between tagged
-synergin and GGAs by immunofluorescence, leading
them to propose that the interaction was in fact physiolog-
ically relevant (Takatsu et al., 2000). In the present study, we
have further addressed this question. We find essentially
complete colocalization between -synergin and AP-1 in
nocodazole-treated cells; however, there is little colocaliza-
tion between AP-1 and the GGAs under these conditions.
Furthermore, in 1A-deficient cells, which have membrane-
associated GGAs but no membrane-associated AP-1, -syn-
ergin is completely cytosolic. Thus, -synergin seems to
show a strong preference for the  appendage in vivo.
Figure 7. Mutagenesis of the
GGA1 appendage domain and ex-
pression of wild-type and mutant
GFP constructs. (a) Wild-type and
mutant GGA1 appendage domain
constructs were fused to GST and
tested for their ability to bind p56
from pig brain cytosol in pulldowns.
Controls include  and  append-
ages, as well as a mutant form of 
(A753D) that prevents binding to
other accessory proteins (Owen et al.,
1999; Kent et al., 2002). Mutations in
hydrophobic residues positioned be-
tween  strands 4 and 5 abolish the
interaction with p56. (b and c) COS
cells were transiently transfected
with GFP coupled to wild-type
GGA1 appendage domain (b) and
labeled with anti-p56 (c). Transfected
cells are marked with asterisks. Even
in low-expressing cells, the p56 has
become essentially completely cyto-
solic. Similar results were obtained
with a GFP-GGA2 appendage do-
main construct (our unpublished
data). (d and e) COS cells were tran-
siently transfected with GFP coupled
to the A563D mutant GGA1 append-
age domain (d) and labeled with an-
ti-p56 (e). The mutant construct has
little or no effect on the distribution
of p56. (f and g) COS cells were tran-
siently transfected with GFP coupled
to the wild-type GGA1 appendage
domain (f) and labeled with anti--
synergin (g). At moderate expression
levels, the construct has little effect on
the distribution of -synergin. h and
i, COS cells were transiently trans-
fected with GFP coupled to the wild-
type  appendage domain (h) and
labeled with anti--synergin (i). The
 appendage domain construct
causes the -synergin to become cy-
tosolic. (j and k) COS cells were tran-
siently transfected with GFP coupled
to the wild-type  appendage do-
main (h) and labeled with anti-p56
(i). At moderate expression levels,
the  appendage domain construct
has little effect on the distribution of
p56. Bar, 20 m.
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The opposite result was obtained for p56. This protein
bound equally well to the GGA and  appendages in both
pulldowns and overlay assays. However, in nocodazole-
treated cells it colocalized with the GGAs but not with AP-1.
Even in transfected cells that were overexpressing p56, the
excess protein remained in the cytosol and was not recruited
onto AP-1–positive membranes. In addition, the distribution
of p56 was not affected in 1A-deficient cells.
Why do p56 and -synergin show such strong preferences
for different appendage domains in vivo, when they can
interact with both in vitro? One possibility is that conditions
inside the cell, such as the presence of other proteins, may
affect their binding. Alternatively, the large excess of ap-
pendage domain constructs in GST pulldowns and overlay
assays may mask binding preferences that become apparent
in the context of the whole cell, where both AP-1 and GGAs
are expressed at relatively low levels. As a first step toward
understanding the molecular basis for the binding prefer-
ences of the two appendages, we have narrowed down the
appendage domain-binding site on p56 to a 15-residue pep-
tide. Interestingly, this peptide contains a sequence, DDF-
GGF, which is related to the DDFXDF motif that has been
proposed as a candidate sequence for binding to the  ap-
pendage (Page et al., 1999; Nogi et al., 2002). Moreover, while
our manuscript was under review, Payne and colleagues
identified the sequence (D/E)2–3FXX as a /GGA append-
age binding motif in yeast (Duncan et al., 2003). The presence
of hydrophobic and acidic residues in these sequences fits in
well with mutagenesis studies on the two appendage do-
mains, which show that both the hydrophobic cleft (Kent et
al., 2002; present study) and conserved basic residues adja-
cent to the cleft (Nogi et al., 2002), contribute to binding.
But if the two appendages can bind to the same motif by
using the same residues, how might specificity be deter-
mined? This may be the function of residues adjacent to the
“strong” binding sites on the two appendages. An analo-
gous situation is seen with the  subunits of the four AP
complexes. All of the  subunits interact with xxYxxx
motifs in the cytoplasmic tails of membrane proteins, but
each subunit has a distinct set of preferences (Ohno et al.,
1998; Owen and Evans, 1998; Owen et al., 2001). Structural
studies on 2 reveal that there is a strong interaction be-
tween the Y and  side chains and residues that are highly
conserved among the different  chains, whereas specificity
is likely to arise from interactions between the “x” residues
and nonconserved regions of the  subunits outside the
binding pocket. Similarly, although the consensus sequence
for binding to GGA and  appendages may be the same,
interactions between amino acids outside the consensus se-
quence and nonconserved residues in the two appendage
domains may determine binding preferences. The answers
to these questions must await the structural characterization
of appendage-peptide complexes. We are currently working
on cocrystallizing the GGA appendage together with the
15-residue peptide.
Very recently, another protein has been reported that can
interact with both  and GGA appendages in vitro. We
found this protein in  appendage domain pulldowns from
A431 cell cytosol and named it epsinR (Hirst et al., 2003).
Three other laboratories have independently identified the
same protein, which has also been called enthoprotin (Wa-
siak et al., 2002) and Clint (Kalthoff et al., 2002) as well as
epsinR (Mills et al., 2003). Yeast homologs of epsinR, Ent3p
and Ent5p, have also recently been identified in two-hybrid
screens for  and GGA appendage domain binding partners
(Duncan et al., 2003). We find that epsinR behaves somewhat
differently from either -synergin or p56, in that its mem-
brane association is independent of both AP-1 and GGAs,
depending instead upon an NH2-terminal ENTH domain
(Hirst et al., 2003). In nocodazole-treated cells epsinR colo-
calizes to some extent with both AP-1 and GGAs (Hirst et al.,
2003), indicating that it interacts with both appendage do-
mains under physiological conditions. Indeed, the high de-
gree of similarity between the GGA and  appendages, and
the observation that they are functionally interchangeable in
yeast, suggests that they are likely to share at least some
binding partners in vivo.
What is the function of p56? In our model shown in Figure
2h, we propose that it may connect the GGAs to another
molecule or molecules via the short COOH-terminal do-
main, which together with the NH2-terminal GGA-binding
domain is the most highly conserved part of p56 when
human and mouse sequences are compared. Interestingly,
this domain shows some homology to a GRIP domain, a
Golgi-targeting domain found in a number of coiled coil
proteins (Munro and Nichols, 1999), although we have been
unable to show any membrane localization when we express
it on its own. According to our model, p56 would be similar
to proteins such as myosin or p115 (Nakamura et al., 1997),
by using its NH2 and COOH terminal ends to bring two
proteins, or possibly a protein and a lipid, together, whereas
the central predicted coiled coil domain would help to in-
crease the efficiency of binding by forming a homodimer.
p56 would also be similar in this respect to several of the
other appendage binding partners. All of the proteins that
have so far been shown to bind directly to the  appendage
also bind at least one other protein or lipid, setting up a
complex network of interactions at the site of endocytic
coated vesicle formation (Slepnev and De Camilli, 2000).
-Synergin is also believed to interact with additional pro-
teins (e.g., SCAMP1), by using its Eps15 homology (DH)
domain (Page et al., 1999; Fernandez-Chacon et al., 2000), and
epsinR interacts in vitro with several phosphoinositides,
including PtdIns(4)P (Hirst et al., 2003; Mills et al., 2003).
Experiments are currently in progress to look for additional
binding partners for p56, by using the short COOH-terminal
domain as bait. Intriguingly, at least two of the alternatively
spliced isoforms of p56 lack the GGA appendage binding
domain, but still contain the coiled coil portion and the
COOH-terminal domain. These proteins may play a regula-
tory role, competing with the more abundant, GGA-binding
isoform for other molecules.
When we transfected cells with either GGA or  append-
age domains coupled to GFP, we were able to change the
distribution of p56 and -synergin, respectively. Even rela-
tively low expression levels had a strong effect, particularly
in the case of the GGA appendage and p56. At very high
expression levels, we started to see effects on the other
partner (our unpublished data). Overexpressing the  ap-
pendage has been shown to inhibit clathrin-mediated endo-
cytosis (Owen et al., 1999), so it is possible that the GGA and
 appendage domains, when expressed on their own at
appropriate levels, may selectively disrupt GGA-mediated
and AP-1–mediated pathways, respectively. There is cur-
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rently some confusion over precisely what the GGAs and
AP-1 are actually doing. Originally, AP-1 was assumed to
facilitate the trafficking of proteins such as the MPRs from
the TGN to an endosomal compartment. The discovery of
the GGAs, and the compelling evidence for their role in
TGN-to-endosome trafficking in both mammals and yeast,
has caused the role of AP-1 to be reassessed. Gene knockout
experiments in both mammals and yeast suggest that in fact
AP-1 may primarily be involved in the retrograde trafficking
of certain cargo proteins from an endosomal compartment
back to the TGN (Meyer et al., 2000, 2001; Valdivia et al.,
2002). Therefore, one current hypothesis is that GGAs and
AP-1 facilitate traffic in opposite directions. Recently, an
alternative hypothesis was proposed, suggesting that the
function of the GGAs might be, at least in part, to “hand
over” cargo to AP-1 (Doray et al., 2002). The double-labeling
experiments on nocodazole-treated cells reported in this
study are consistent with both hypotheses, because both
hypotheses predict that GGAs should act before AP-1. We
find that GGAs and p56 show good colocalization with the
TGN marker TGN46, as well as with other proteins associ-
ated with the Golgi stack (Figure 4, g–i; our unpublished
observations). In contrast, AP-1 shows little colocalization
with Golgi markers (Figure 4, d–f), suggesting that it is
primarily associated with a post-TGN compartment. So far,
we have not seen convincing colocalization in nocodazole-
treated cells between AP-1 and any of the marker proteins
we have investigated, so the identity of this compartment is
not yet known. However, the use of GGA and  appendage
domains as dominant negatives may help to establish the
precise functions not only of accessory proteins such as p56
and -synergin but also of the GGAs and of AP-1.
With the exception of their appendage domains, the GGAs
have always been assumed to be structurally distinct from
the heterotetrameric adaptor complexes (Boehm and Boni-
facino, 2001; Robinson and Bonifacino, 2001). However, this
work, in combination with the recently solved structure of
the AP-2 core complex (Collins et al., 2002), reveals an inter-
esting relationship between the GGAs and the large subunits
of adaptor complexes. The GGAs are composed of four
domains: the VHS domain, the GAT domain, the hinge-like
domain, and the appendage domain. The trunks of the adap-
tor large subunits are -helical structures with a high degree
of similarity to the VHS domain of the GGAs (Misra et al.,
2002; Shiba et al., 2002). Secondary structure predictions of
the GAT domain suggest that this region also has a predom-
inantly -helical secondary structure (our unpublished ob-
servations). In the present study, we have demonstrated
conclusively that the appendage domain of the GGAs is
structurally related to the appendages of the adaptor large
subunits. When pooled, these data show that the GGAs and
adaptor large subunits share a very similar structural orga-
nization despite a lack of sequence homology: an NH2-
terminal -helical structure connected by a flexible, clathrin-
binding linker to a  sheet appendage domain. The GGAs
may thus be similar, both structurally and functionally, to
the ancestral large chain from which both adaptor and
coatomer subunits are thought to have derived.
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